These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 30117731
1. Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) Complexes. Jin S, Hao Y, Zhu Z, Muhammad N, Zhang Z, Wang K, Guo Y, Guo Z, Wang X. Inorg Chem; 2018 Sep 04; 57(17):11135-11145. PubMed ID: 30117731 [Abstract] [Full Text] [Related]
2. Targeting Energy Metabolism by a Platinum(IV) Prodrug as an Alternative Pathway for Cancer Suppression. Jin S, Guo Y, Song D, Zhu Z, Zhang Z, Sun Y, Yang T, Guo Z, Wang X. Inorg Chem; 2019 May 06; 58(9):6507-6516. PubMed ID: 31013065 [Abstract] [Full Text] [Related]
3. Complexes of oxoplatin with rhein and ferulic acid ligands as platinum(iv) prodrugs with high anti-tumor activity. Tan MX, Wang ZF, Qin QP, Zou BQ, Liang H. Dalton Trans; 2020 Feb 07; 49(5):1613-1619. PubMed ID: 31942585 [Abstract] [Full Text] [Related]
4. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes. Choi S, Vastag L, Larrabee YC, Personick ML, Schaberg KB, Fowler BJ, Sandwick RK, Rawji G. Inorg Chem; 2008 Feb 18; 47(4):1352-60. PubMed ID: 18220340 [Abstract] [Full Text] [Related]
5. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents. Zhang Z, Wang X, Luo C, Zhu C, Wang K, Zhang C, Guo Z. Chem Asian J; 2017 Jul 04; 12(13):1659-1667. PubMed ID: 28556606 [Abstract] [Full Text] [Related]
6. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions. Savino S, Marzano C, Gandin V, Hoeschele JD, Natile G, Margiotta N. Int J Mol Sci; 2018 Jul 14; 19(7):. PubMed ID: 30011897 [Abstract] [Full Text] [Related]
7. The Effects of Newly Synthesized Platinum(IV) Complexes on Cytotoxicity and Radiosensitization of Human Tumour Cells In Vitro. Petrovic M, Popovic S, Baskic D, Todorovic M, Djurdjevic P, Ristic-Fira A, Keta O, Petkovic V, Koricanac L, Stojkovic D, Jevtic V, Trifunovic S, Todorovic D. Anticancer Res; 2020 Sep 14; 40(9):5001-5013. PubMed ID: 32878788 [Abstract] [Full Text] [Related]
8. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles. Komeda S, Takayama H, Suzuki T, Odani A, Yamori T, Chikuma M. Metallomics; 2013 May 14; 5(5):461-8. PubMed ID: 23608770 [Abstract] [Full Text] [Related]
9. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes. Siddik ZH, al-Baker S, Thai G, Khokhar AR. Anticancer Drug Des; 1994 Apr 14; 9(2):139-51. PubMed ID: 8166929 [Abstract] [Full Text] [Related]
10. Synthesis and biological evaluation of novel platinum complexes of imidazolyl-containing bisphosphonates as potential anticancer agents. Qiu L, Lv G, Cao Y, Chen L, Yang H, Luo S, Zou M, Lin J. J Biol Inorg Chem; 2015 Dec 14; 20(8):1263-75. PubMed ID: 26531104 [Abstract] [Full Text] [Related]
11. Effective platinum(IV) prodrugs conjugated with lonidamine as a functional group working on the mitochondria. Chen H, Chen F, Hu W, Gou S. J Inorg Biochem; 2018 Mar 14; 180():119-128. PubMed ID: 29253663 [Abstract] [Full Text] [Related]
12. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells. Muscella A, Calabriso N, De Pascali SA, Urso L, Ciccarese A, Fanizzi FP, Migoni D, Marsigliante S. Biochem Pharmacol; 2007 Jun 30; 74(1):28-40. PubMed ID: 17481588 [Abstract] [Full Text] [Related]
13. Mitochondria-targeted platinum(II) complexes induce apoptosis-dependent autophagic cell death mediated by ER-stress in A549 cancer cells. Wang FY, Tang XM, Wang X, Huang KB, Feng HW, Chen ZF, Liu YN, Liang H. Eur J Med Chem; 2018 Jul 15; 155():639-650. PubMed ID: 29935437 [Abstract] [Full Text] [Related]
14. Targeting ROS-AMPK pathway by multiaction Platinum(IV) prodrugs containing hypolipidemic drug bezafibrate. Qiao X, Gao YY, Zheng LX, Ding XJ, Xu LW, Hu JJ, Gao WZ, Xu JY. Eur J Med Chem; 2021 Nov 05; 223():113730. PubMed ID: 34388483 [Abstract] [Full Text] [Related]
15. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents. Gao X, Liu S, Shi Y, Huang Z, Mi Y, Mi Q, Yang J, Gao Q. Eur J Med Chem; 2017 Jan 05; 125():372-384. PubMed ID: 27688191 [Abstract] [Full Text] [Related]
16. Novel platinum(IV) complexes induce rapid tumor cell death in vitro. Kaludjerović GN, Miljković D, Momcilović M, Djinović VM, Mostarica Stojković M, Sabo TJ, Trajković V. Int J Cancer; 2005 Sep 01; 116(3):479-86. PubMed ID: 15818622 [Abstract] [Full Text] [Related]
17. A hybrid platinum drug dichloroacetate-platinum(II) overcomes cisplatin drug resistance through dual organelle targeting. Zhang Y, Guo G, Ma B, Du R, Xiao H, Yang X, Li W, Gao Y, Li Y, Jing X. Anticancer Drugs; 2015 Aug 01; 26(7):698-705. PubMed ID: 25811961 [Abstract] [Full Text] [Related]